Cardiac Anderson-Fabry disease: Lessons from a 25-year-follow up
Sarcomeric hypertrophic cardiomyopathy (HCM) is the most common genetic cause of unexplained left ventricular hypertrophy and has no specific treatment. Anderson-Fabry disease (AFD) is rare and usually multisystemic, but occasionally expresses clinically as a predominantly cardiac phenotype mimickin...
Main Authors: | Dulce Brito, Gabriel Miltenberger–Miltenyi, Oana Moldovan, Carmen Navarro, Hugo Costa Madeira |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-04-01
|
Series: | Revista Portuguesa de Cardiologia |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0870255114000808 |
Similar Items
-
Role of cardiac imaging in Anderson-Fabry cardiomyopathy
by: Walter Serra, et al.
Published: (2019-01-01) -
Anderson-Fabry Disease
by: Idalina Beirão MD, PhD, et al.
Published: (2016-09-01) -
Fabry Disease Therapy: State-of-the-Art and Current Challenges
by: Olga Azevedo, et al.
Published: (2020-12-01) -
Cardiac Imaging in Anderson-Fabry Disease: Past, Present and Future
by: Roberta Esposito, et al.
Published: (2021-05-01) -
Biomarkers in Anderson–Fabry Disease
by: Irene Simonetta, et al.
Published: (2020-10-01)